The gut microbiota metabolite propionate ameliorates intestinal epithelial barrier dysfunction-mediated Parkinson’s disease via the AKT signaling pathway-Reference-Cited by-同舟云学术

The gut microbiota metabolite propionate ameliorates intestinal epithelial barrier dysfunction-mediated Parkinson’s disease via the AKT signaling pathway

Published:2021-01-18 Issue:3 Volume:32 Page:244-251
ISSN:0959-4965
Container-title:NeuroReport
language:en
Short-container-title:

Author:

Huang Tingting,Shi Hongjuan,Xu Yuanfeng,Ji Lili

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Neuroscience

Reference25 articles.

1. Diagnosis and treatment of parkinson disease: a review.;Armstrong;JAMA,2020

2. Integrated and patient-centred management of Parkinson’s disease: a network model for reshaping chronic neurological care.;Bloem;Lancet Neurol,2020

3. Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors.;Klingelhoefer;Nat Rev Neurol,2015

4. Structural alterations of the intestinal epithelial barrier in Parkinson’s disease.;Clairembault;Acta Neuropathol Commun,2015

5. The intestinal barrier in Parkinson’s disease: current state of knowledge.;van IJzendoorn;J Parkinson’s Dis,2019

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Probing the alterations in mice cecal content due to high-fat diet;Food Chemistry;2024-10

2. The role of gut-derived short-chain fatty acids in Parkinson's disease;Neurogenetics;2024-09-13

3. Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights;Life Sciences;2024-08

4. Isoquercitrin alleviates lipopolysaccharide-induced intestinal mucosal barrier damage in mice by regulating TLR4/MyD88/NF-κB signaling pathway and intestinal flora;Food & Function;2024

5. The epithelial barrier: The gateway to allergic, autoimmune, and metabolic diseases and chronic neuropsychiatric conditions;Seminars in Immunology;2023-11